Lepage, Côme
244  Ergebnisse:
Personensuche X
?
1

Bevacizumab plus FOLFIRI after failure of platinum–etoposid..:

Walter, Thomas ; Lievre, Astrid ; Coriat, Romain...
info:eu-repo/semantics/altIdentifier/doi/10.1016/s1470-2045(23)00001-3.  , 2023
 
?
2

Treatment, outcome, and prognostic factors in non-metastati..:

Vendrely, Véronique ; Lemanski, Claire ; Pommier, Pascal...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109542.  , 2023
 
?
3

Treatment, outcome, and prognostic factors in non-metastati..:

Vendrely, Véronique ; Lemanski, Claire ; Pommier, Pascal...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109542.  , 2023
 
?
4

Panitumumab in combination with chemoradiotherapy for the t..:

Vendrely, Véronique ; Ronchin, Philippe ; Minsat, Mathieu...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109742.  , 2023
 
?
5

Treatment, outcome, and prognostic factors in non-metastati..:

Vendrely, Véronique ; Lemanski, Claire ; Pommier, Pascal...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109542.  , 2023
 
?
6

Treatment, outcome, and prognostic factors in non-metastati..:

Vendrely, Véronique ; Lemanski, Claire ; Pommier, Pascal...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109542.  , 2023
 
?
7

Treatment, outcome, and prognostic factors in non-metastati..:

Vendrely, Véronique ; Lemanski, Claire ; Pommier, Pascal...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109542.  , 2023
 
?
8

Treatment, outcome, and prognostic factors in non-metastati..:

Vendrely, Véronique ; Lemanski, Claire ; Pommier, Pascal...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109542.  , 2023
 
?
9

Panitumumab in combination with chemoradiotherapy for the t..:

Vendrely, Véronique ; Ronchin, Philippe ; Minsat, Mathieu...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109742.  , 2023
 
?
10

Panitumumab in combination with chemoradiotherapy for the t..:

Vendrely, Véronique ; Ronchin, Philippe ; Minsat, Mathieu...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109742.  , 2023
 
?
12

Panitumumab in combination with chemoradiotherapy for the t..:

Vendrely, Véronique ; Ronchin, Philippe ; Minsat, Mathieu...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109742.  , 2023
 
?
13

Treatment, outcome, and prognostic factors in non-metastati..:

Vendrely, Véronique ; Lemanski, Claire ; Pommier, Pascal...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109542.  , 2023
 
?
14

Panitumumab in combination with chemoradiotherapy for the t..:

Vendrely, Véronique ; Ronchin, Philippe ; Minsat, Mathieu...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109742.  , 2023
 
?
15

Treatment, outcome, and prognostic factors in non-metastati..:

Vendrely, Véronique ; Lemanski, Claire ; Pommier, Pascal...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.radonc.2023.109542.  , 2023
 
1-15